Go to the CFIDS/M.E. Information Page
Mary Schweitzer's Essays on ME/CFS
Full testimony to CFSAC 20 November 2006

Canadian Consensus Document for Diagnosing and Treating M.E./CFS (2003)
Overview; Bruce M. Carruthers, MD and Margorie I. van de Sande

Short Version Bibliography

Ablashi DV, Eastman HB, Owen CB et al. Frequent HHV-6 antibody and HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. C Clin Virol 16(3):179-191, May 1, 2000.

Bennett RM. Fibromyalgia, chronic fatigue syndrome, and myofascial pain. Cur Opin Rheum 10(2):95-103,1998.

Boda WL, Natelson BH, Sisto SA, Tapp WN. Gait abnormalities in patients with the chronic fatigue syndrome. J Neurol Sci 131(2):156-161, Aug. 1995.

Bouholaigah I, Rowe PC, Kan J, Calkins H. The relationship between neurally-mediated hypotension and the chronic fatigue syndrome. Journal of the American Medical Association 274 (12):961-967 Sept. 27, 1995.

Bruno RL, et al. Polio Encephalitis and brain generator model of Post Viral Fatigue. J CFS 2(2,3):5-27, 1996.

Buchwald D, Cheney PR, Peterson DL, et al. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpes virus type 6 infection. Ann Intern Med 116(2):103-113, 1992.

Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM, Bested AC, Flor-Henry P, Joshi P, Powles ACP, Sherkey JA, van de Sande MI. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols. J CFS 11(1):7-115, 2003.

Codero DL, Sisto SA, Tapp WN, et al. Decreased vagal power during treadmill walking in patients with chronic fatigue syndrome. Clin Auton Res 6(6):329-333, 1994.

Costa DC, Tannock C, Brostoff J. Brainstem perfusion is impaired in chronic fatigue syndrome. Q J. Med 88:767-773, 1995.

De Becker P, McGregor N, De Meirleir K. A definition-based analysis of symptoms in a large cohort of patients with chronic fatigue syndrome. J Inter Med 250:234-240, 2001.

De Becker P, Roeykens J, Reynders M, et al. Exercise capacity in chronic fatigue syndrome. Arch Intern Med 160 (21):3270-3277, Nov. 27, 2000.

De Lange F, Kalkman J, Bleijenberg G, et al. Gray matter volume reduction in the chronic fatigue syndrome. NeuroImage 26:777-781,2005.

De Meirleir K, Bisbal C, Campine I, et al, a 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome. Am J Med 108 (2):99-105, 2000.

Demitrack MA, Crofford LJ. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Ann NY Acad Sci 840:684-697, May 1, 1998.

Dowsett EG, Colby J. Long-term sickness absence due to ME/CFS in UK schools: an epidemiological study with medical and educational implications. J CFS 3(2):29-42, 1997.

Fischer B., Le Bon O, Hoffmann G, et al. Sleep anomalies in the chroni fatigue syndrome. A comorbid study. Neuropsychobiol 35(3):115-122, 1997.

Fukuda K, Straus SE, Hickie I et al. Chronic Fatigue Syndrome: a comprehensive approach to its definition and study. Annals Med 121:953-959, 1994.

Ichise M, Salit I, Abbey S, et al. Assessment of regional cerebral perfusion by Tc-HMPAO SPECT in Chronic Fatigue Syndrome. Nuclear Med Commun 13:767-772, 1992.

Inbar O, Dlin R, Rotstein A, et al. Physiological responses to incremental exercise in patients with chronic fatigue syndrome. Med Scie Sports Exer 33(9):1463-1470, Sept. 2001.

Jason LA, Richman, JA, Rademaker AW et al. A Community-based study of Chronic Fatigue Syndrome. Arch Intern Med 159:2129-2147, Oct. 1999.

Jason LA, in Munson P, editor. Stricken: Voices from the Hidden Epidemic of Chronic Fatigue Syndrome. Haworth Press, New York 2000, p. 4.

Jason LA, Torres-Harding SR, Jurgens A, Helgerson J. Comparing the Fukuda et al. Criteria and the Canadian Case Definition for Chronic Fatigue syndrome, JCFS 12 (1):27-52, 2004.

Joyce J, Hotopf M, Wessely S. The prognosis of chronic fatigue and chronic fatigue syndromes: a systematic review. QJ Med 90:223-233, 1997.

Kaushik N, Fear D, Richards SCM et al. Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome J Clin Pathol 58:826-832, 2005.

Komaroff AL. The biology of the Chronic Fatigue Syndrome. Amer J Med 108:99-105, Feb 2000.

La Manca JJ, Sisto SA, DeLuca, J, et al. Influence of exhaustive treadmill exercise on cognitive functioning in chronic fatigue syndrome. J Inter Med 250:234-240,2001.

La Manca JJ, Sisto SA, DeLuca, J, et al. Influence of exhaustive treadmill exercise on cognitive functioning in chronic fatigue syndrome. Am J Med 105(3A):59S-65S, Sept 27, 1998.

Lange G, Holodny AI, Lee HJ, et al. Quantitative assessment of cerebral ventricular volumes in chronic fatigue syndrome. Appl Neuropsychol 8(1):23-30, 2001.

Lange G, Stefferne J, Cook DB, et al. Objective evidence of cognitive complaints in Chronic Fatigue Syndrome: A BOLD fMRI study of verbal working memory. Neuroimage 26(2):513-24, June 1, 2005.

Lange G, Wang S, DeLuca J, Natelson BH. Neuroimaging in chronic fatigue syndrome. Am J Med 105(3A):50S-53S, 1998.

Lerner AM, Zervos M, Dworkin HJ, et al. New cardiomyopathy: pilot study of intravenous Ganciclovir in a subset of the chronic fatigue syndrome. Infec Dis in Clin Pract 6:110-117, 1997.

Okada T, Tanaka M, Kuratsune H, et al. Mechanisms underlying fatigue: A voxel-based morphometric study of chronic fatigue syndrome. BMC Neurol 4:14, 2004.

Patarco-Monero R, Mark T, Fltcher M, Klimas NG. The immunology of chronic fatigue syndrome. J CFS 6(3/4):59-107, 2000.

Peckerman A, LaManca JJ, Dahl KA, et al. Abnormal impedance cardiography predicts symptom severity in Chronic Fatigue Syndrome. Amer J Med Science 326(2):55-60, Aug 2003.

Roelens S, Herst CV, D’Haese A, et al. G-actin cleavagae parallels 2-5A-Dependent Rnase L cleavage in peripheral blood mononuclear cells-relevance to a possible serum-based screening test. J CFS 8 (3/4):63-82, 2001.

Sheperd C. Pacing and exercise in chronic fatigue syndrome. Physiother 87(8):395-396, Aug 2001.

Snell CF, Vanness JM, Stayer DR, Stevens SR. Exercise capacity and immune function in male and female patients with chronic fatigue syndrome (CFS). In Vivo 19(2):387-90, Mar-Apr. 2005

Streeten DH. Role of impaired lower-limb venous innervation in the pathogenesis of the chronic fatigue syndrome. Amer J Med Sci 321:163-167, Mar. 2001.

Streeten DH, Tomas D, Bell DS. The roles of orthostatic hypotension, orthostatic tachycardia and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome. Am J Med 320(1):1-8, Jul 2000.

Tirelli U, Chierichetti F, Tavio M, et al. Brain positron emission toography (PET) in chronic fatigue syndrome: preliminary data [in process citation]. Amer J Med 105 (3A):trS-t8S, Sept. 28, 1998.

Vojdani A, Choppa PC, Lapp CS. Downregulation of Rnase-L inhibitor correlates with upregulation of interferon- induced proteins (2-5A synthetase and Rnase L) in patients with chronic fatigue immune dysfunction syndrome. J Clin Lab Immunol 50 (1):1-16, 1998.

Wessely S, Nimnuan C, Sharp M. Functional somatic syndromes: one or many? Lancet 354(9182):936-939, Sept 11, 1999.

Go to the CFIDS/M.E. Information Page
Mary Schweitzer's Essays on ME/CFS
Full testimony to CFSAC 20 November 2006